SEARCH

SEARCH BY CITATION

References

  • 1
    Schaller, M., Schackert, C., Korting, H.C., Januschke, E., Hube, B. (2000) Invasion of Candida albicans correlates with expression of secreted aspartic proteinases during experimental infection of human epidermis. J. Invest. Dermatol. 114, 712717.DOI: 10.1046/j.1523-1747.2000.00935.x
  • 2
    De Bernardis, F., Mondello, F., Scaravelli, G., Pachi, A., Girolamo, A., Agatensi, L., Cassone, A. (1999) High aspartyl proteinase production and vaginitis in human immunodeficiency virus-infected women. J. Clin. Microbiol. 5, 13761380.
  • 3
    Schaller, M., Hube, B., Ollert, M.W., Schäfer, W., Borg-von Zepelin, M., Thoma-Greber, E., Korting, H.C. (1999) In vivo expression and localization of Candida albicans secreted aspartyl proteinases during oral candidiasis in HIV-infected patients. J. Invest. Dermatol. 112, 383386.DOI: 10.1046/j.1523-1747.1999.00525.x
  • 4
    Borg-von Zepelin, M., Beggah, S., Boggian, K., Sanglard, D., Monod, M. (1998) The expression of the secreted aspartyl proteinases Sap4 to Sap6 from Candida albicans in murine macrophages. Mol. Microbiol. 28, 543554.
  • 5
    Douglas, L.J. (1988) Candida proteinases and candidosis. Crit. Rev. Biotechnol. 8, 121129.
  • 6
    Ray, T.L. & Payne, C.D. (1990) Comparative production and rapid purification of Candida acid proteinase from protein-supplemented cultures. Infect. Immun. 58, 508514.
  • 7
    Cutler, E. (1991) Putative virulence factors of Candida albicans. Annu. Rev. Microbiol. 45, 187218.
  • 8
    Ruchel, R., De Bernardis, F., Ray, T.L., Sullivan, P.A., Cole, G.T. (1992) Candida acid proteinases. J. Med. Vet. Mycol. 30, 123132.
  • 9
    White, T.C. & Agabian, N. (1995) Candida albicans secreted aspartyl proteinases: isoenzyme pattern is determined by cell type, levels are determined by environmental factors. J. Bacteriol. 177, 52155221.
  • 10
    Kaminishi, H., Miyaguchi, H., Tamaki, T., Suenega, N., Hisamatsu, M., Mihashi, I., Matsumoto, H., Maeda, H., Hagihara, Y. (1995) Degradation of humoral host defense by Candida albicans proteinase. Infect. Immun. 63, 984988.
  • 11
    Monod, M., Togni, G., Hube, B., Sanglard, D. (1994) Multiplicity of genes encoding secreted aspartic proteinases in Candida species. Mol. Microbiol. 13, 357368.
  • 12
    Hube, B., Monod, M., Schofield, D.A., Brown, A.J., Gow, N.A. (1994) Expression of seven members of the gene family encoding secretory aspartyl proteinases in Candida albicans. Mol. Microbiol. 14, 8799.
  • 13
    Monod, M., Hube, B., Hess, D., Sanglard, D. (1998) Differential regulation of SAP8 and SAP9, which encode two new members of the secreted aspartic proteinase family in Candida albicans. Microbiology 144, 27312737.
  • 14
    Niimi, M., Niimi, K., Cannon, R.D. (1997) Temperature-related expression of the vacuolar aspartic proteinase (APR1) gene and β-N-acetylglucosaminidase (HEX1) gene during Candida albicans morphogenesis. FEMS Microbiol. Lett. 148, 247254.DOI: 10.1016/s0378-1097(97)00042-6
  • 15
    Sanglard, D., Hube, B., Monod, M., Odds, F.C., Gow, N.A.R. (1997) A triple deletion of the secreted aspartyl proteinase genes SAP4, SAP5, and SAP6 of Candida albicans causes attenuated virulence. Infect. Immun. 65, 35393546.
  • 16
    Schaller, M., Korting, H.C., Schafer, W., Bastert, J., Chen, W., Hube, B. (1999) Secreted aspartic proteinase (Sap) activity contributes to tissue damage in a model of human oral candidosis. Mol. Microbiol. 34, 169180.
  • 17
    De Bernardis, F., Agatensi, L., Ross, I.K., Emerson, G.W., Lorenzini, R., Sullivan, P.A., Cassone, A. (1990) Evidence for a role for secreted aspartate proteinase of Candida albicans in vulvovaginal candidiasis. J. Infect. Dis. 161, 12761283.
  • 18
    Beggah, S., Lechenne, B., Reichard, U., Foundling, S., Monod, M. (2000) Intra- and intermolecular events direct the propeptide-mediated maturation of the Candida albicans secreted aspartic proteinase sap1p. Microbiology 146, 27652773.
  • 19
    Smolenski, G., Sullivan, P.A., Cutfield, S.M., Cutfield, J.F. (1997) Analysis of secreted aspartic proteinases from Candida albicans: purification and characterization of individual Sap1, Sap2 and Sap3 isoenzymes. Microbiology 143, 349356.
  • 20
    Koelsch, G., Tang, J., Loy, J.A., Monod, M., Jackson, K., Foundling, S.I., Lin, X. (2000) Enzymic characteristics of secreted aspartic proteases of Candida albicans. Biochim. Biophys. Acta 1480, 117131.
  • 21
    Cutfield, S.M., Dodson, E.J., Anderson, B.F., Moody, P.C.E., Marshall, C.J., Sullivan, P.A., Cutfield, J.F. (1995) The crystal structure of a major secreted aspartic proteinase from Candida albicans in complexes with two inhibitors. Structure 15, 12611271.
  • 22
    Abad-Zapatero, C., Goldman, R., Muchmore, S.W., Hutchins, Ch, Oie, T., Stewart, K., Cutfield, S.M., Cutfield, J.F., Foundling, S.I., Ray, T.L. (1996) Structure of secreted aspartic proteinases from Candida. Implications for the design of antifungal agents. Protein Sci. 5, 640652.
  • 23
    Fusek, M., Smith, E.A., Monod, M., Dunn, B.M., Foundling, S.I. (1994) Extracellular aspartic proteinases from Candida albicans, Candida tropicalis, and Candida parapsilosis yeasts differ substantially in their specificities. Biochemistry 33, 97919799.
  • 24
    Horn, R., Wong, B., Kiehn, T.E., Armstrong, D. (1985) Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. Rev. Infect. Dis. 7, 646655.
  • 25
    Komshian, S.V., Uwaydah, A.K., Sobel, J.D., Crane, L.R. (1989) Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. Rev. Infect. Dis. 11, 379390.
  • 26
    Symersky, J., Monod, M., Foundling, S.I. (1997) High-resolution structure of the extracellular aspartic proteinase from Candida tropicalis yeast. Biochemistry 36, 1270012710.DOI: 10.1021/bi970613x
  • 27
    Zaugg, CH., Borg-von Zepelin, M., Reichard, U., Sanglard, D., Monod, M. (2001) Secreted aspartic proteinase family of Candida tropicalis. Infect. Immun. 1, 405412.
  • 28
    De Viragh, P.A., Sanglard, D., Togni, G., Falchetto, R., Monod, M. (1993) Cloning and sequencing of two Candida parapsilosis genes encoding acid proteases. J. Gen. Microbiol. 139, 335342.
  • 29
    Ruchel, R., Boning, B., Borg, M. (1986) Characterization of a secretory proteinase of Candida parapsilosis and evidence for the absence of the enzyme during infection in vitro. Infect. Immun. 53, 411419.
  • 30
    Macdonald, F. (1984) Secretion of inducible proteinase by pathogenic Candida species. Sabouraudia 22, 7982.
  • 31
    Fusek, M., Smith, E.A., Monod, M., Foundling, S.I. (1993) Candida parapsilosis expresses and secretes two aspartic proteinases. FEBS Lett. 327, 108112.
  • 32
    Sono, E., Masuda, T., Takesako, K., Kato, I., Uchida, K., Murayama, S.Y., Yamagughi, H. (1992) Comparison of secretory acid proteinases from Candida tropicalis, C. parapsilosis and C. albicans. Microbiol. Immunol. 36, 10991104.
  • 33
    Christenson, J.C., Guruswamy, A., Mukwaya, G., Rettig, P.J. (1987) Candida lusitaniae: an emerging human pathogen. Pediatr. Infect. Dis. J. 6, 755757.
  • 34
    Hadfield, T.L., Smith, M.B., Winn, R.E., Rinaldi, M.G., Guerra, C. (1987) Mycoses caused by Candida lusitaniae. Rev. Infect. Dis. 9, 10061012.
  • 35
    Hazen, K.C. (1995) New and emerging yeast pathogens. Clin. Microbiol. Rev. 8, 462478.
  • 36
    Holzshu, D.L., Presley, H.L., Miranda, M., Phaff, H.J. (1979) Identification of Candida lusitaniae as an opportunistic yeast in human. J. Clin. Microbiol. 10, 202205.
  • 37
    Sarma, P.S., Durairaj, P., Padhye, A.A. (1993) Candida lusitaniae causing fatal meningitis. Postgrad. Med. J. 69, 878880.
  • 38
    Blinkhorn, R.J., Adelstein, D., Spagnuolo, P.J. (1989) Emergence of a new opportunistic pathogen, Candida lusitaniae. J. Clin. Microbiol. 27, 236240.
  • 39
    Merz, W.G. (1984) Candida lusitaniae: frequency of recovery, colonization, infection, and amphotericin B resistance. J. Clin. Microbiol. 20, 11941195.
  • 40
    Capobianco, J.O., Lerner, C.G., Goldman, R.C. (1992) Application of a fluorogenic substrate in the assay of proteolytic activity and in the discovery of a potent inhibitor of Candida albicans aspartic proteinase. Anal. Biochem. 204, 96102.
  • 41
    Fallon, K., Bausch, K., Noonan, J., Huguenel, E., Tamburini, P. (1997) Role of aspartic proteases in disseminated Candida albicans infection in mice. Infect. Immun. 65, 551556.
  • 42
    Kretschmar, M., Hube, B., Bertsch, T., Sanglard, D., Merker, R., Schröder, M., Hof, H., Nichterlein, T. (1999) Germ tubes and proteinase activity contribute to virulence of Candida albicans in murine peritonitis. Infect. Immun. 12, 66376642.
  • 43
    Ruchel, R., Ritter, B., Schaffrinski, M. (1990) Modulation of experimental systemic murine candidosis by intravenous pepstatin. Int. J. Med. Microbiol. 273, 391403.
  • 44
    Zotter, C., Haustein, U.F., Schonborn, C., Grimmecke, H.D., Wand, H. (1990) The effect of pepstatin A on Candida albicans infection in mice. Dermatol. Monatsschr. 176, 189198.
  • 45
    Korting, H.C., Schaller, M., Eder, G., Hamm, G., Bohmer, U., Hube, B. (1999) Effects of the human immunodeficiency virus (HIV) proteinase inhibitors saquinavir and indinavir on in vitro activities of secreted aspartyl proteinases of Candida albicans isolates from HIV-infected patients. Antimicrob. Agents Chemother. 43, 20382042.
  • 46
    Zingman, B.S. (1996) Resolution of refractory AIDS-related mucosal candidiasis after initiation of didanosine plus saquinavir. N. Engl. J. Med. 334, 16741675.
  • 47
    Hoegl, L., Thoma-Greber, E., Rocken, M., Korting, H.C. (1998) Shift from persistent oral pseudomembranes to erythematous candidosis in a human immunodeficiency virus (HIV)-infected patient upon combination treatment with an HIV protease inhibitor. Mycoses 41, 213217.
  • 48
    Diz Dios, P., Ocampo, A., Miralles, C., Otero, I., Iglesias, I., Rayo, N. (1999) Frequency of oropharyngeal candidiasis in HIV-infected patients on protease inhibitor therapy. Oral Surg. Oral Med. O. 87, 437441.
  • 49
    Bugelski, P.J., Kaplan, J.M., Hart, T.K., Miller, J., Laydon, J.T., Lee, J.C., Dreyer, G.B., Kirsh, R. (1992) Effect of a human immunodeficiency virus protease inhibitor on human monocyte function. AIDS Res. Hum. Retrov. 8, 19511958.
  • 50
    Diz Dios, P., Otero Varela, I., Iglesias Martin, I., Ocampo Hermida, A., Martinez Vazquez, C. (1999) Failure of indinavir to inhibit Candida albicans in vitro. Eur. J. Clin. Microbiol. Infect. Dis. 18, 755756.
  • 51
    Tumminello, F.M., Bernacki, R.J., Gebbia, N., Leto, G. (1993) Pepstatins: aspartic proteinase inhibitors having potential therapeutic applications. Med. Res. Rev. 13, 199208.
  • 52
    Monod, M., Borg-von Zepelin, M., Telenti, A., Sanglard, D. (1999) The inhibition of Candida-albicans-secreted aspartic protease by three different HIV protease inhibitors. Dermatology 198, 412414.
  • 53
    Gruber, A., Berlit, J., Speth, C., Lass-Florl, C., Kofler, G., Nagl, M., Borg-von Zepelin, M., Dierich, M.P., Wurzner, R. (1999) Dissimilar attenuation of Candida albicans virulence properties by human immunodeficiency virus type 1 protease inhibitors. Immunobiology 201, 133144.
  • 54
    Gruber, A., Speth, C., Lukasser-Vogl, E., Zangerle, R., Borg-von Zepelin, M., Dierich, M.P., Wurzner, R. (1999) Human immunodeficiency virus type 1 protease inhibitor attenuates Candida albicans virulence properties in vitro. Immunopharmacology 41, 227234.DOI: 10.1016/s0162-3109(99)00035-1
  • 55
    Cassone, A., De Bernardis, F., Torosantucci, A., Tacconelli, E., Tumbarello, M., Cauda, R. (1999) In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors. J. Infect. Dis. 180, 448453.DOI: 10.1086/314871
  • 56
    Cauda, R., Tacconelli, E., Tumbarello, M., Morace, G., De Bernardis, F., Torosantucci, A., Cassone, A. (1999) Role of protease inhibitors in preventing recurrent oral candidosis in patients with HIV infection: a prospective case-control study. J. Acquir. Immune Defic. Syndr. 21, 2025.
  • 57
    Brožková, K., Křižová, I., Pavlíčková, L., Hradílek, M., Fusek, M., Ruml, T., Souček, M., Pichová, I. (1999) Peptidomimetic inhibitors of extracellular aspartic proteinases of Candida albicans and Candida tropicalis. Collect. Czech. Chem. C. 64, 130137.
  • 58
    Jouin, P. & Castro, B. (1987) Stereospecific synthesis of N-protected statine and its analogues via chiral tetramic acid. J. Chem. Soc. Perkin Trans. 1, 11771187.
  • 59
    Bodanszky, M. & Bodanszky, A. (1984) The Practice of Peptide Synthesis. Springer Verlag, Berlin.
  • 60
    Williams, J.W. & Morrison, J.F. (1979) The kinetics of reversible tight-binding inhibition. Methods Enzymol. 63, 437467.
  • 61
    Wright, R.J., Carne, A., Hieber, A.D., Lamont, I.L., Emerson, G.W., Sullivan, P.A. (1992) A second gene for a secreted aspartate proteinase in Candida albicans. J. Bacteriol. 174, 78487853.
  • 62
    Togni, G., Sanglard, D., Falchetto, R., Monod, M. (1991) Isolation and nucleotide sequence of the extracellular acid protease gene (ACP) from the yeast Candida tropicalis. FEBS Lett. 286, 181185.
  • 63
    Sato, T., Nagai, K., Shibazaki, M., Abe, K., Takebayashi, Y., Lumanau, B., Rantiatmodjo, R.M. (1994) Novel aspartyl protease inhibitors, YF-0200R-A and B. J. Antibiot. 47, 566570.
  • 64
    Sato, T., Shibazaki, M., Yamaguchi, H., Abe, K., Matsumoto, H., Shimizu, M. (1994) Novel Candida albicans aspartyl protease inhibitor. II. A new pepstatin-ahpatinin group inhibitor, YF-044P-D. J. Antibiot. 47, 588590.
  • 65
    Milewski, S., Mignini, F., Covelli, I., Borowski, E. (1994) Specific inhibition of acid proteinase secretion in Candida albicans by Lys-Nva-FMDP. J. Med. Vet. Mycol. 32, 111.
  • 66
    Hube, B. (1996) Candida albicans secreted aspartyl proteinases. Curr. Top. Med. Mycol. 7, 5569.
  • 67
    Borg-von Zepelin, M. & Ruchel, R. (1988) Expression of extracellular acid proteinase by proteolytic Candida spp. during experimental infection of oral mucosa. Infect. Immun. 56, 626631.
  • 68
    Ray, T.L. & Payne, C.D. (1988) Scanning electron microscopy of epidermal adherence and cavitation in murine candidiasis: a role for Candida acid proteinase. Infect. Immun. 56, 19421949.
  • 69
    Ollert, M.W., Sohnchen, R., Korting, H.C., Ollert, U., Brautigam, S., Brautigam, W. (1993) Mechanisms of adherence of Candida albicans to cultured human epidermal keratinocytes. Infect. Immun. 61, 45604568.
  • 70
    Colina, A.R., Aumont, F., Deslauriers, N., Belhumeur, P., De Repenigny, L. (1996) Evidence for degradation of gastrointestinal mucin by Candida albicans secretory aspartyl proteinase. Infect. Immun. 64, 45144519.
  • 71
    Borg-von Zepelin, M., Meyer, I., Thomssen, R., Wurzner, R., Sanglard, D., Telenti, A., Monod, M. (1999) HIV-protease inhibitors reduce cell adherence of Candida albicans strains by inhibition of yeast secreted aspartic proteases. J. Invest. Dermatol. 113, 747751. DOI: 10.1046/j.1523-1747.1999.00747.x